Glatiramer Acetate Injection 20 mg/mL, 40 mg/mL Suppliers & Bulk Manufacturers
Available Forms: SQ injection
Available Strengths: 20 mg/mL, 40 mg/mL
Reference Brands: Copaxone(US)
Category: Multiple sclerosis
Glatiramer Acetate modulates the immune system by shifting T-cell responses from pro-inflammatory to anti-inflammatory, reducing autoimmune attack on the nervous system. It decreases relapse frequency, slows disease progression, and minimizes lesion development in multiple sclerosis. Benefits include improved symptom control, fewer relapses, and enhanced quality of life for MS patients.
Product Description:
Glatiramer Acetate, marketed as Copaxone, is approved in the US by the FDA and in the EU via EMA for multiple sclerosis. Regulatory approval requires a detailed dossier including clinical efficacy, safety data, manufacturing quality, and pharmacovigilance plans. In the US, the FDA reviews comprehensive clinical and manufacturing details, while the EMA ensures compliance with regional safety and quality standards.
Glatiramer Acetate Injection — third party manufacturing & bulk supply
Glatiramer Acetate Injection 20 mg/mL, 40 mg/mL is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:
What to include when you enquire
- Destination market — determines which manufacturers hold the right site-level approvals
- First order quantity and estimated annual volume
- Whether you need a registration dossier or the product is already registered
- Packaging, labelling and language requirements
- Incoterms and required shelf life
Manufacturers of Glatiramer Acetate Injection listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding. Narcotic drugs and controlled substances are supplied strictly against valid import and export permits issued by the competent authorities.
Request a quote for Glatiramer Acetate Injection →The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Frequently Asked Questions
Related Products
Lamotriginevdispersible Tablets
Strength:
XR: 25 mg, 50 mg, 100 mg, 200 mg; IR: 25 mg, 100 mg, 200 mg, 300 mg
Form: Tablets(IR & ER)
Reference Brands: Lamictal, Lamictal XR(EU & US)
View Details
Dalfampridine
Strength:
10 mg
Form: Extended-Release tablets (XR)
Reference Brands: Ampyra(US)
View Details
Tizanidine Tablets/Capsules
Strength:
2 mg and 4 mg
Form: Oral Capsules/Tablets
Reference Brands: Zanaflex (US)
View Details
Baclofen Tablets:
Strength:
10 mg and 20 mg
Form: Tablet
Reference Brands: Lioresal, Gablofen(US & EU)
View DetailsQuick Response Guaranteed | Verified Suppliers
